Prominent Psychiatrist Introduces Breakthrough Treatment for Addiction

NEW YORK, April 17, 2025 ~ New York City - Dr. Eileen DiFrancesco, a renowned psychiatrist and psychopharmacologist, has recently launched a new website for individuals seeking treatment for addiction. With over two decades of experience in treating neuropsychiatric disorders, Dr. DiFrancesco is excited about the latest developments in addiction treatment.

Having trained at Ivy League schools and worked in prestigious medical institutions, Dr. DiFrancesco has seen firsthand the lack of effective medication for addiction. However, she believes that there is finally a breakthrough in this area with the use of semaglutide, a drug originally developed for diabetes and weight loss.

According to Dr. DiFrancesco, patients taking semaglutide have reported not only a decrease in overconsumption of food but also a reduced interest in alcohol. This is not just a coincidence or side effect, as studies published in JAMA, Nature, and Science Direct have shown that this medication targets neural circuits involved in reward and satiety.

More on Rezul News

• NBA Champion Lamar Odom Launches Anti-Addiction Meme Coin, Ushering in a Disruptive Innovation in Web3
• Aureli Construction Sets the Standard for Seamless Home Additions in Greater Boston
• Harvest Properties Acquires Two San Francisco Bay Area Self Storage Facilities for $44.2 Million
• Georgia's Traditions of Braselton to Host Spring Open House Event
• ScreenPoints Puts Film Investors in the Credits—and in the Money With New FinTech Platform

Semaglutide works by mimicking a natural hormone called glucagon-like peptide-1 (GLP-1), which activates GLP-1 receptors throughout the brain's reward pathway. This pathway is responsible for providing a sense of pleasure or reward when we engage in behaviors essential for our survival, such as eating healthy foods and nurturing relationships.

However, addictive substances can hijack this reward pathway and become the focus of an individual's life. This is where semaglutide comes into play - by activating GLP-1 receptors in the reward pathway, it reduces the sense of reward from addictive substances like alcohol, nicotine, cocaine, and opioids.

Studies have shown that semaglutide can significantly reduce the risk of alcohol use disorders and substance use disorder-related hospitalizations. It has also been found to reduce alcohol intake in pre-clinical models and associated with non-volitional reduction in the use of various addictive substances.

Dr. DiFrancesco believes that this serendipitous finding is truly amazing and offers hope for those struggling with addiction. When combined with existing treatments, semaglutide can be a powerful tool in treating this destructive and debilitating disease.

If you or someone you love is seeking treatment for addiction, Dr. DiFrancesco's Psychiatry practice offers a comprehensive approach that includes the use of semaglutide. For more information, please visit their website at www.xsrxdoctor.com.

---

Show All News | Report Violation